Find
6738
related chemicals for you
2-N-Propyl-4-Methyl-6-(1'-Methylbenzimidazole-2-Yl)Benzimidazole; 2-N-Propyl-4-Methyl-6-(1-Methylbenzimidazole-2-Yl)Benzimidazole; 2-N-Propyl-4-Methyl-6-(1-Methylbenzimidazol-2-Yl)-Benzimidazole; Telmisartan Impurity A (2-N-Propyl-4-Methyl-6-(1-Methylbenzimidazole-2-Yl)Benzimidazole); Telmisartan Impurity A; Telmisartan Related Compound A; 4-Methyl-2-Propyl-6-Benzimidazolecarboxylicacid; 2-Propyl-4-Methyl-6-(1-Methylbenzimidazol-2-Yl)Benzimidazole; 2-N-Propyl-4-Methyl-6-(1-Methyl Benzimidazole-2-Yl) Benzimidazole; 2-n-Propyl-4-Methyl-6-(1-Methylbenzimida zole-2-Ylbenzimidazole)
Brief Introduction
This product ia an impurity found in Telmisartan.
CAS:154229-19-3
Molecular Formula:C24H31NO
(3Beta)-17-(3-Pyridinyl)-Androsta-5,16-Dien-3-Ol; Androsta-5,16-Dien-3-Ol, 17-(3-Pyridinyl)-, (3Beta)-; Cb 7598; Cb-7598; Unii-G819A456D0; Abiraterone(Cb-7598); 17-(3-Pyridyl)Androsta-5,16-Dien-3Beta-Ol; Cb7598; Zytiga
Brief Introduction
Abiraterone acetate (INN, USAN, BAN, JAN) (brand names Zytiga, Abiratas, Abretone, Abirapro) is a steroidal antiandrogen, specifically an androgen synthesis inhibitor, used in combination with prednisone in metastatic castration-resistant prostate cancer (previously called hormone-resistant or hormone-refractory prostate cancer) – i.e., prostate cancer not responding to androgen deprivation or treatment with androgen receptor antagonists. It is a prodrug to the active agent abiraterone, and is marketed by Janssen Biotech under the trade name Zytiga. In addition, Intas Pharmaceuticals markets the drug under the trade name Abiratas, Cadila Pharmaceuticals markets the drug as Abretone, and Glenmark Pharmaceuticals as Abirapro. Abiraterone acetate was approved by the United States Food and Drug Administration on April 28, 2011. The FDA press release made reference to a phase III clinical trial in which abiraterone use was associated with a median survival of 14.8 months versus 10.9 months with placebo; the study was stopped early because of the successful outcome.
CAS:154361-50-9
Molecular Formula:C15H22FN3O6
Pentyl [1-(3,4-Dihydroxy-5-Methyl-Oxolan-2-Yl)-5-Fluoro-2-Oxo-Pyrimidin-4-Yl]Aminoformate; Xeloda; Capecytabine; Ro 09-1978; Captabin; 5'-Deoxy-5-Fluoro-N-[(Pentyloxy)Carbonyl]Cytidine; Ro-9-1978; 5'-Deoxy-5-Fluoro-N4-[(Pentyloxy)Carbonyl]Cytidine; Cpecitabine; Capecitibine; Ro 09-1978/000; Capcitabine; 5'-Deoxy-5-Fluorocytisine; Pentyl (1-((2R,3R,4S,5R)-3,4-Dihydroxy-5-Methyltetrahydrofuran-2-Yl)-5-Fluoro-2-Oxo-1,2-Dihydr
Brief Introduction
Capecitabine, an antimetabolite fluoropyrimidine deoxynucleoside carbamate that can be converted to 5-FU in vivo, was developed by Roche under the trade name hiloda and is able to inhibit cell division and interfere with RNA and protein synthesis. For further treatment of paclitaxel and advanced primary or metastatic breast cancer including patients refractory to chemotherapeutic regimens with anthracyclines. It is mainly used for the treatment of advanced primary or metastatic breast, rectal, colon and gastric cancer.
CAS:164650-44-6
Molecular Formula:C18H22F2N4O
(2R,3R)-2-(2,4-Difluorophenyl)-3-(4-Methylenepiperidin-1-yl)-1-(1H-1,2,4-Triazol-1-yl)Butan-2-ol; Efinaconazol; Efinaconazolum
Brief Introduction
Efinaconazole is the first triazole antifungal drug for external use. It has been developed for the treatment of local distal lateral subungual fungi (dlso) and can be used for the treatment of onychomycosis.
CAS:1711-07-5
Molecular Formula:C7H4ClFO
m-Fluorobenzoyl Chloride; 3-Fluorobenzoylchloride; m-Fluorobenzoic acid Chloride; 3-Fluorobenzoic acid Chloride; m-Fluorobenzoylchloride; meta-Fluorobenzoyl Chloride
Brief Introduction
3-Fluorobenzoyl chloride can be used as organic synthesis intermediate and pharmaceutical intermediate, mainly in laboratory R & D process and chemical production process. Also used as dyes, pesticides, pharmaceutical intermediates.
Inquiry ( 
10
 
/ 10
 )
Clear All
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >